Speaking at the British Neuroscience Association annual meeting in Harrogate, in association with Neuroscience Ireland, Dr Finn and his team from the department of pharmacology and therapeutics at the National University of Ireland, reported studies of behaviour in response to the action of endocannabinoids, substances in the brain that fine-tune a range of the body’s functions and emotions.
Their research in rats has shown that if the endocannabinoid signalling is blocked, fear and anxiety increased and lasted longer, whilst the suppression of pain normally observed in response to fear was abolished. Conversely, administration of drugs which prevent the breakdown of endocannabinoids enhances suppression of pain in response to fear. “If the endocannabinoid system is blocked, animals feel pain immediately, but if it is fully functioning, it suppresses the pain for a while,” said Dr Finn.
Smoking cannabis may mimic the effects of the body’s own endocannabinoids. Around 15 percent of people who smoke cannabis experience anxiety, suggesting that the cannabinoid system may represent a new way to treat anxiety disorders.
“Our research - and that of others - implies that if you can enhance endocannabinoids in the brain, this might be a route for treating phobias, stress and trauma associated with aversive memories and experiences. Ultimately, it might even help treat post-traumatic stress disorder,” said Dr Finn. In certain situations, such as when soldiers are injured, the pain is suppressed. “Perhaps this delay has evolved to allow a person to carry on and get themselves to safety before the pain kicks in. We are now getting a handle on what mediates profound suppression of pain,” he said.
From understanding the basic mechanisms of pain in relation to traumatic experiences, the goal would be to try and manipulate the system therapeutically. “But this is not so straightforward,” said Dr Finn. “We have to find out whether fear is needed to induce the analgesic effect. Can you separate the two - and is it wise to?”
The next stage of his research, which is funded by Science Foundation Ireland and the Irish Health Research Board, will be to study further the brain regions involved and the chemical alterations in the brain during fear-induced pain suppression.
Elaine Snell | Source: alphagalileo
Further information: www.bna.org.uk/welcome_07.htm
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News